Inactive Instrument

Chelsea Therapeutics International Ltd. Stock

Equities

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Chelsea Therapeutics Presents Efficacy and Safety Data for NORTHERA at International Congress of Parkinson's Disease and Movement Disorders	14-06-12	GL
Chelsea Therapeutics : Newman Ferrara LLP : Announces Investigation of Chelsea Therapeutics International Ltd.	14-05-09	BU
Chelsea Therapeutics : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Chelsea Therapeutics International, Ltd. Stockholders	14-05-08	BU
Chelsea Therapeutics Joins NORD in Promoting Awareness for Rare Disease Day	14-02-28	GL
Chelsea Therapeutics International Ltd. : Chelsea Therapeutics Announces FDA Accelerated Approval of NORTHERA™ (Droxidopa) for the Treatment of Symptomatic NOH	14-02-18	PU

14-05-08

Sector

	1st Jan change	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	-3.30%	102B
REGENERON PHARMACEUTICALS, INC.	+1.79%	96.84B
ARGENX SE	-0.44%	21.48B
BIONTECH SE	-18.35%	20.82B
GENMAB A/S	-7.45%	18.6B
WUXI APPTEC CO., LTD.	-40.31%	16.81B
BEIGENE, LTD.	-26.84%	13.78B
NEUROCRINE BIOSCIENCES, INC.	+0.59%	13.4B
SAREPTA THERAPEUTICS, INC.	+20.86%	11.06B